Nonalcoholic Fatty Liver Disease Clinical Trials

124 clinical trials for Nonalcoholic Fatty Liver Disease across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — RECRUITING · NA
• Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease — RECRUITING
• Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With Obesity — RECRUITING
• Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease — RECRUITING
• iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss — RECRUITING · NA
• Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD) — RECRUITING
• Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases — RECRUITING
• To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease — RECRUITING
• Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly — RECRUITING · NA
• Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD — RECRUITING · PHASE2
• Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis — RECRUITING
• Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD — RECRUITING · PHASE4
• Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT） — RECRUITING · PHASE4
• Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus — RECRUITING
• Observational Study About Patients Diagnosed With NAFLD — RECRUITING
• Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease — RECRUITING
• The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease — NOT_YET_RECRUITING · NA
• Phase 2b Study of GSK4532990 in Adults With NASH — ACTIVE_NOT_RECRUITING · PHASE2
• Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016) — COMPLETED · PHASE2
• Vitamin E Dosing Study — COMPLETED · PHASE2
• Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis — ACTIVE_NOT_RECRUITING
• Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease — ACTIVE_NOT_RECRUITING
• A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) — COMPLETED · PHASE2
• Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US — TERMINATED · PHASE2
• A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor — COMPLETED · PHASE1
• Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis — NOT_YET_RECRUITING · NA
• Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease — COMPLETED · PHASE1
• Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) — COMPLETED · PHASE2
• Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD) — COMPLETED · PHASE4
• De Novo Lipogenesis in Severity of NAFLD — COMPLETED
• Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease — COMPLETED · PHASE2
• Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver Disease — OTHER · NA
• A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria — WITHDRAWN · PHASE1
• Postprandial Lipotoxicity and Nonalcoholic Fatty Liver Disease — COMPLETED · NA
• An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease — COMPLETED · NA
• Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines — OTHER · NA
• Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease — OTHER
• A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001) — COMPLETED · PHASE2
• Time Restricted Feeding on Nonalcoholic Fatty Liver Disease — COMPLETED · NA
• The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects — COMPLETED · PHASE1
• Characterization of health monitoring patterns in patients with metabolic diseases — NOT_YET_RECRUITING
• The University of Michigan Wellness for Liver Health Study — COMPLETED · PHASE1
• Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis — COMPLETED · PHASE2
• Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease — COMPLETED · PHASE2
• Fatty Liver Disease in Obese Children — COMPLETED · PHASE1
• A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis — COMPLETED · PHASE2
• Weight Gain After Smoking Cessation and NAFLD — COMPLETED
• A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis — COMPLETED · PHASE2
• Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD — COMPLETED · PHASE1
• Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease — TERMINATED · PHASE2

Refine this search